Search Results for:

AlzChem Group AG: strong performance in Q4, EBITDA 2020 +7.4%
Press Release - 19. March 2021
Trostberg, March 19, 2021 – AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in ...
Read more

“Ich hatte immer einen Plan B”
In the media - 22. December 2020
Smart Investor im Gespräch mit dem Firmensanierer Prof. Dr. Peter Löw über seine unternehmerischen Abenteuer, Mitarbeiter, Geld, Gold und Glück Weiterlesen

LIVIA Group acquires major part of the Professional Solutions business of IRIS Group (a Canon company)
Press Release - 7. September 2020

LIVIA Group acquires major part of the Professional Solutions business of IRIS Group (a Canon company) The new entity will …
Read more

LIVIA Group and IRIS Group – a Canon company – reach an agreement on the acquisition of Hybrid Technology Solutions BU.
Press Release - 12. June 2020

Munich, June 12th 2020 – LIVIA Group announces the signing of an agreement for the acquisition of the IRIS HTS …
Read more

AlzChem Group AG increases sales in the first quarter of 2020 by 2.8% to EUR 94.7 million
Press Release - 12. May 2020

Trostberg, May 12, 2020 – AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in …
Read more

AlzChem to supply components for corona tests
Press Release - 6. May 2020

As a supplier of raw materials for the pharmaceutical industry, AlzChem is now also helping to produce “corona tests”: intermediate …
Read more

Cookie Policy
- 21. February 2020

This site uses cookies – small text files that are placed on your machine to help the site provide a …
Read more

LIVIA announces Management Buy Out of Ostend Basic Chemicals NV
Press Release - 16. January 2020
Munich / Oostende, 16 January 2020 – The Management of Ostend Basic Chemicals N.V. (OBC) has signed an agreement with ...
Read more

Die Schlossherren von Hofhegnenberg laden zum 20. Kipferlmarkt
In the media - 5. December 2019
In the media - 05.12.2019 Zum Jubiläum des Kipferlmarktes Hofhegnenberg im Schloss haben die Löws ein historisches Kinderkarussell organisiert und ...
Read more

LIVIA GROUP ANNOUNCES THE ACQUISITION OF PRIME EUROPEAN THERAPEUTICALS S.P.A. FROM ALBANY MOLECULAR RESEARCH INC.
Press Release - 1. August 2019
LIVIA Corporate Development SE announces the acquisition of Prime European Therapeuticals S.p.A. (“Euticals”), from Albany Molecular Research Inc. (“AMRI”).
LIVIA Group
LIVIA News
Downloads
LIVIA Investor